Lipopolysaccharide stimulates HIV-1 entry and degradation in human macrophages
Open Access
- 1 August 2001
- journal article
- other
- Published by SAGE Publications in Innate Immunity
- Vol. 7 (4) , 271-276
- https://doi.org/10.1177/09680519010070040801
Abstract
The bacterial endotoxin LPS is a potent stimulator of monocyte and macrophage activation and has been shown to protect differentiated macrophages from de novo infection by HIV-1. However, the mechanisms of this inhibitory activity of LPS are not fully understood. We investigated the effect of LPS on the early post-binding steps of HIV-1 replication in primary macrophages. Paradoxically, when applied together with the virus, LPS stimulated entry of HIV-1 into macrophages, as judged by the amount of internalized HIV-1 RNA and p24. This stimulatory activity did not depend on receptors used for entry and did not require new protein synthesis. However, internalized viral RNA and p24 were rapidly degraded in LPS-stimulated macrophages. Surprisingly, while degradation of HIV-1 p24 in LPS-treated cells was inhibited by bafilomycin A1, HIV-1 RNA was not protected by this agent, suggesting that viral RNA is degraded by a pH-independent mechanism. These results indicate that LPS stimulates both virus uptake and virus degradation in macrophages.Keywords
This publication has 26 references indexed in Scilit:
- Exposure to bacterial products renders macrophages highly susceptible to T-tropic HIV-1.Journal of Clinical Investigation, 1998
- Macrophages as a Source of HIV During Opportunistic InfectionsScience, 1997
- C–C Chemokines Released by Lipopolysaccharide (LPS)-stimulated Human Macrophages Suppress HIV-1 Infection in Both Macrophages and T CellsThe Journal of Experimental Medicine, 1997
- Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected IndividualsThe Journal of Experimental Medicine, 1997
- HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5Nature, 1996
- Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease.The Journal of Experimental Medicine, 1995
- Activation of human monocyte--derived macrophages with lipopolysaccharide decreases human immunodeficiency virus replication in vitro at the level of gene expression.Journal of Clinical Investigation, 1991
- Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression.The Journal of Experimental Medicine, 1990
- Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro.The Journal of Experimental Medicine, 1989
- Role of mononuclear phagocytes and accessory cells in human immunodeficiency virus type I infection of the brainAnnals of Neurology, 1988